Budealfa 9mg Tablet CR
Marketer
Alniche Life Sciences Pvt Ltd
Salt Composition
Budesonide (9mg)
Overview Budealfa 9mg Tablet CR
Budafa CR 9mg tablets are corticosteroids indicated for moderate-to-severe ulcerative colitis. They alleviate associated pain and inflammation. This medication can be administered with or without food; consistent daily dosing is crucial for optimal efficacy. Discontinuing treatment prematurely should be discussed with your physician, as it could exacerbate symptoms. Common side effects may include gastrointestinal discomfort and mood alterations. Furthermore, Budafa CR 9mg may impair your immune response, increasing infection susceptibility. Report any infection indicators, like fever or pharyngitis, to your doctor immediately.
Primary Ingredients of Budealfa 9mg Tablet CR
The provided text is "undefined," which offers no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Budealfa 9mg Tablet CR
Managing ulcerative colitis
Major Benefits of Budealfa 9mg Tablet CR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Budealfa 9mg Tablet CR whole; do not break, crush, or chew it. While you can take it with or without food, consistency is key—take it at the same time each day.
Common Side effects of Budealfa 9mg Tablet CR:
- Abdominal pain
- Constipation
- Headache
- Depression
- Joint pain
- Increased risk of infection
- Muscle pain
- Muscle weakness
- Muscle twitching
- Irritability
- Nausea
How to use Budealfa 9mg Tablet CR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 9mg Budealfa CR tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended for optimal results.
How Budealfa 9mg Tablet CR works:
Budealfa 9mg Controlled-Release tablets contain a steroid that inhibits the formation of inflammatory mediators. This action prevents ulceration and inflammation in the colonic and rectal mucosa, thereby alleviating pain.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Budealfa 9mg Tablet CR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Budealfa 9mg Tablet CR during pregnancy might pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Budealfa 9mg tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Budealfa 9mg Tablet CR on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Extended-release Budealfa 9mg tablets are likely safe for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Budealfa 9mg CR tablets cautiously, potentially requiring dosage modification. Consult a physician. Budealfa 9mg CR tablets are contraindicated in patients exhibiting severe hepatic dysfunction due to insufficient supporting clinical data.
What if you forget to take Budealfa 9mg Tablet CR :
Should you forget a Budealfa 9mg Tablet CR dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Budealfa 9mg Tablet CR
Label | Value |
---|---|
Type of Compound | Inhaled corticosteroids |
Potential for Dependence | None. |
Medication Classification | Gastrointestinal system |